checkAd

     129  0 Kommentare OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report

    WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environmental, Social and Governance (ESG) report for 2024.

    As a company that provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey, we remain dedicated to aligning our mission with our responsibilities as a corporate citizen.

    “Stakeholders are increasingly interested in a company’s commitment to environmental, social, and governance responsibilities,” stated Marion Odence-Ford, General Counsel & Chief Compliance Officer. “We are proud to continue our ESG efforts to drive positive change and establish sustainable practices throughout our organization. We strive to uphold ESG best practices as a core part of our mission and look forward to building on our progress.”

    OptimizeRx is committed to adapting to our ever-changing world. We demonstrate this by continuously improving and transparently reporting on our ESG efforts. Our ESG report uses a standardized framework developed by the World Economic Forum, which includes 21 core metrics across four categories: Governance, Planet, People and Prosperity.

    2024 ESG Report Highlights:

    Governance:

    • The pursuit of responsible governance is a top-down endeavor, and the Company’s Board of Directors and the Nominating & Governance Committee have worked closely with the Executive Team to ensure our business strategies and practices align with our corporate governance policies.
    • This year’s ESG Report establishes a trendline from the prior year’s materiality matrix to identify the critical issues affecting our business and stakeholders over time.
    • In January 2024, our efforts to foster a more inclusive organization bore fruit when the Board of Directors adhered to the Parity Pledge and added Catherine Klema as a Board member. The Board also appointed Lynn O’Connor Vos as Chairperson. Both Ms. Klema and Ms. Vos bring valuable industry expertise and diversify the Board’s composition.
    Seite 1 von 4



    globenewswire
    0 Follower
    Autor folgen
    Verfasst von globenewswire
    OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) - OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, …